XIAP and neoplasm: Park et al. generated anti-HER2 ILP that encapsulated doxorubicin, and reported identical prolonged blood circulation compared with control PEGylated liposome without antibody conjugation, as well as enhanced therapeutic outcomes in four different HER2-overexpressing tumor xenograft models [98].